BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 10753730)

  • 1. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel.
    Porat N; Barkai G; Jacobs MR; Trefler R; Dagan R
    J Infect Dis; 2004 Feb; 189(3):385-92. PubMed ID: 14745695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine.
    Somech I; Dagan R; Givon-Lavi N; Porat N; Raiz S; Leiberman A; Puterman M; Peled N; Greenberg D; Leibovitz E
    Vaccine; 2011 Jun; 29(25):4202-9. PubMed ID: 21497634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
    Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.
    McEllistrem MC; Adams JM; Patel K; Mendelsohn AB; Kaplan SL; Bradley JS; Schutze GE; Kim KS; Mason EO; Wald ER
    Clin Infect Dis; 2005 Jun; 40(12):1738-44. PubMed ID: 15909260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
    Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.
    Marom T; Avraham E; Cinamon U; Tamir SO
    J Microbiol Immunol Infect; 2017 Oct; 50(5):714-717. PubMed ID: 26507672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunisation with a pneumococcal 7-valent conjugate vaccine.
    Dagan R
    Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice.
    Fraser D; Givon-Lavi N; Bilenko N; Dagan R
    Clin Infect Dis; 2001 Aug; 33(4):421-7. PubMed ID: 11462175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.